07/11/2016
https://congress.gov...
"This is the kind of issue that can and should be tackled on a bipartisan basis."
"Look, no physician wants to tell a patient that they cannot receive the care they need because there is no treatment but because the product is simply not available and we won't provide alternatives i..."
"Statement, dated February 7, 2012, of the Biotechnology Industry Organization, submitted by Mr. Pitts."
"A lot of folks where I come from, they can't afford a $50 substitute for a $20 product that they have been taking for way too many years."